Anzeige
Mehr »
Login
Samstag, 18.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
287 Leser
Artikel bewerten:
(1)

Albert Plastic Surgery's Revolutionary Closed Rhinoplasty Procedure

Finanznachrichten News

A Global Approach for All Primary and Revision Cases

NEW YORK, NY / ACCESSWIRE / August 27, 2024 / Contrary to some surgeons' views of traditional closed or endonasal approaches, the limited incision closed rhinoplasty technique can be reliably employed for all rhinoplasty cases regardless of their complexity. With a resurgence of interest from the public in scarless and preservation nose surgery, Albert Plastic Surgery's innovative closed rhinoplasty approach has quickly become a sought-after solution for patients in NYC and beyond.

Rhinoplasty

Rhinoplasty
Rhinoplasty procedure in NYC, by Dr. Albert, will ensure your comfort by administering general anesthesia. He will address the specific aspects of your nose that you've discussed, such as its size, shape, and appearance.



Dr. Albert's approach comes with a wealth of benefits

Limited incision rhinoplasty has many advantages for both the patient and the surgeon. It is one of the most reliable techniques available and has a low rate of complications and revision requests. The technique minimizes soft tissue damage and preserves blood supply, enhancing safety while reducing downtime and optimizing results. External scarring is completely avoided.

It is an easier technique for surgeons to master, allowing for widespread adoption, especially among novice plastic surgeons. With conventional closed rhinoplasty, there are multiple endonasal incisions to master. Dr. Albert's version of closed rhinoplasty at Albert Plastic Surgery simplifies the procedure by requiring surgeons to learn just a single incision, making the technique easier to understand, absorb, and replicate.

Additionally, the endonasal approach allows surgeons to place cartilage grafts more precisely without suture fixation. The surgical team can make real-time aesthetic evaluations, as the nasal skin envelope remains intact throughout the procedure. This helps surgeons meet their patients' cosmetic expectations more accurately and reliably, resulting in higher patient satisfaction.

Dr. Albert - Surgical pioneer and innovator

Dr. Albert comes from a family of NYC-based physicians, which deepened his commitment to his craft. From early on, he viewed the field of plastic and reconstructive surgery as the arena where he could positively impact people's lives. He strives to remain ahead of the curve as a surgeon, incorporating the latest progressive techniques to perfect outcomes, reduce downtime, and minimize postoperative scarring.

Dr. Albert is devoted to producing natural-looking improvements that align with each patient's unique vision for a more attractive, inviting appearance. He completed elite Fellowship training in aesthetic surgery at among the world's most prestigious training institutions - the Manhattan Eye, Ear, and Throat Hospital. In 2017, he was chosen as the director of this renowned fellowship program, where he continues to advance his innovative surgical techniques.

Dr. Albert spent six years as a resident and chief resident in Plastic Surgery at the University of Massachusetts. A clinical editor and Aesthetic Society Board Member, he's renowned for his expertise in closed limited incision rhinoplasty, a technique he's mastered and shared globally through a recent publication in Aesthetic Plastic Surgery.

Learn more about Dr. Albert and his innovative closed rhinoplasty technique.

Contact Information
Mark Albert
MD, FACS
cindy@albertplasticsurgery.com
332-239-2255

SOURCE: Albert Plastic Surgery

.

View the original press release on newswire.com.

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.